Among Asia’s ~180 million people with depression, over 91% receive no formal treatment, while aging populations are driving rising demand for Parkinson’s, dementia, and post-stroke neurotherapy. Next-generation real-time neural electric-field visualization, 10× accelerated treatment, wire-free design, and biophilic product language reduce pre-treatment anxiety by 73%. Its decentralized architecture redefines healthcare delivery by enabling community-based neurotherapy across Asia.